European Parliament leaves open door for some non-viables to jump ship
This article was originally published in Clinica
Executive Summary
The European Parliament is putting forward proposed amendments to the Commission's proposed Advanced Therapies Medicinal Products (ATMP) Regulation, seeking to specify exactly when the combination of a medical device and a human tissue-engineered product should be encompassed in the scope of the Directive, Clinica has learnt.